In Marburg, three pharmaceutical companies are significantly reducing their workforce, reflecting a crisis in Germany's pharmaceutical industry. As the companies adjust, it is expected that Marburg will see a reduction of at least 1,000 jobs in the pharmaceutical sector within months. The CSL Group, an Australian firm, is particularly impacted, as its subsidiary CSL Innovation, which employed 500 people, is shutting down, and another division, CSL Behring, might lose up to 450 positions.